Repair of cisplatin-DNA adducts by prote
β
Sandra L. Jones; Ian D. Hickson; Adrian L. Harris; Paul R. Harnett
π
Article
π
1994
π
John Wiley and Sons
π
French
β 678 KB
## Abstract Human ovarian carcinoma exhibits a spectrum of responses to treatment with cisplatin, ranging from marked sensitivity to relative resistance. Variations in the efficiency with which cells repair cisplatinβDNA adducts may in part determine cisplatin sensitivity. We have investigated the